应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
03320 华润医药
开市前 11-05 09:12:10
5.600
-0.020
-0.36%
最高
5.600
最低
5.600
成交量
0.00
今开
5.600
昨收
5.620
日振幅
0.00%
总市值
351.82亿
流通市值
351.82亿
总股本
62.83亿
成交额
0.00
换手率
0.00%
流通股本
62.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
华润医药10月31日主力资金流出130万元 连续3日减仓
市场透视 · 10-31
华润医药10月31日主力资金流出130万元 连续3日减仓
华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%
阿斯达克财经 · 10-31
华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%
华润医药(03320)：东阿阿胶前9个月实现净利润11.52亿元，同比增长46.74%
智通财经 · 10-30
华润医药(03320)：东阿阿胶前9个月实现净利润11.52亿元，同比增长46.74%
华润医药：华润三九前三季度净利润32.45亿元 同比增加20.39%
新浪港股 · 10-28
华润医药：华润三九前三季度净利润32.45亿元 同比增加20.39%
华润医药(03320.HK)附属华润双鹤首九个月赚14.12亿人民币 增长2%
阿斯达克财经 · 10-27
华润医药(03320.HK)附属华润双鹤首九个月赚14.12亿人民币 增长2%
2024国谈今日开启：默沙东、华润医药等多家药企现身首日，今年对创新药要求或更高
红星新闻 · 10-27
2024国谈今日开启：默沙东、华润医药等多家药企现身首日，今年对创新药要求或更高
华润医药(03320)：华润三九(000999.SZ)前三季度净利润32.45亿元 同比增加20.39%
智通财经 · 10-25
华润医药(03320)：华润三九(000999.SZ)前三季度净利润32.45亿元 同比增加20.39%
华润医药(03320)：江中药业前三季度实现净利润6.84亿元，同比增长8.98%
智通财经 · 10-25
华润医药(03320)：江中药业前三季度实现净利润6.84亿元，同比增长8.98%
华润医药(03320)：昆药集团前三季度实现净利润3.91亿元，同比减少1.44%
智通财经 · 10-25
华润医药(03320)：昆药集团前三季度实现净利润3.91亿元，同比减少1.44%
华润医药(03320)：华润双鹤前三季度净利润约14.12亿元，同比增长2.03%
智通财经 · 10-25
华润医药(03320)：华润双鹤前三季度净利润约14.12亿元，同比增长2.03%
瑞银：首予华润医药“买入”评级 相信其未来几年将继续跑羸同行
美港电讯 · 10-25
瑞银：首予华润医药“买入”评级 相信其未来几年将继续跑羸同行
华润医药(03320.HK)附属华润博雅生物首九月赚4.12亿人民币 倒退13%
阿斯达克财经 · 10-24
华润医药(03320.HK)附属华润博雅生物首九月赚4.12亿人民币 倒退13%
华润医药(03320)：华润博雅生物前三季度净利润约4.12亿元，同比减少13.01%
智通财经 · 10-24
华润医药(03320)：华润博雅生物前三季度净利润约4.12亿元，同比减少13.01%
瑞银：首予华润医药(03320)“买入”评级 目标价9.9港元
智通财经 · 10-24
瑞银：首予华润医药(03320)“买入”评级 目标价9.9港元
《大行》瑞银首次覆盖华润医药(03320.HK) 评级“买入”目标价9.9元
阿斯达克财经 · 10-24
《大行》瑞银首次覆盖华润医药(03320.HK) 评级“买入”目标价9.9元
南向资金10月22日净卖出华润医药207.15万股 连续3日减持
市场透视 · 10-23
南向资金10月22日净卖出华润医药207.15万股 连续3日减持
华润医药10月22日主力资金流入713万元 连续3日加仓
市场透视 · 10-22
华润医药10月22日主力资金流入713万元 连续3日加仓
【港股通】华润医药(03320)附属拟至多1.2亿人币增持江中药业
金吾财讯 · 10-22
【港股通】华润医药(03320)附属拟至多1.2亿人币增持江中药业
华润医药(03320.HK)附属江中药业控股股东拟最多1.2亿人民币增持
阿斯达克财经 · 10-21
华润医药(03320.HK)附属江中药业控股股东拟最多1.2亿人民币增持
华润医药(03320)：华润江中拟增持江中药业股份 增持总金额为0.6亿元-1.2亿元
智通财经 · 10-21
华润医药(03320)：华润江中拟增持江中药业股份 增持总金额为0.6亿元-1.2亿元
公司概况
公司名称：
华润医药
所属市场：
SEHK
上市日期：
--
主营业务：
华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案，如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。
发行价格：
--
{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":5.6,"timestamp":1730769064342,"preClose":5.62,"halted":0,"volume":0,"delay":0,"floatShares":6282510461,"shares":6282510461,"eps":0.6703067,"marketStatus":"开市前","marketStatusCode":1,"change":-0.02,"latestTime":"11-05 09:12:10","open":5.6,"high":5.6,"low":5.6,"amount":0,"amplitude":0,"askPrice":5.6,"askSize":500,"bidPrice":5.6,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":0.6484543479349186,"exchange":"SEHK","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730770200000},"adr":0,"listingDate":1477584000000,"adjPreClose":5.62,"dividendRate":0.046264,"openAndCloseTimeList":[[1730770200000,1730779200000],[1730782800000,1730793600000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320/wiki","defaultTab":"wiki","newsList":[{"id":"2479773061","title":"华润医药10月31日主力资金流出130万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479773061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479773061?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:15","pubTimestamp":1730362552,"startTime":"0","endTime":"0","summary":"10月31日, 华润医药股价跌1.26%，报收5.50元，成交金额5811万元，换手率0.17%，振幅2.87%，量比1.31。华润医药今日主力资金净流出130万元，连续3日净流出，上一交易日主力净流出220万元，今日环比减少40.91%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为52.63%，平均跌幅为1.81%。该股近5个交易日下跌5.05%，主力资金累计净流出201万元；近20日主力资金累计净流出2501万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031161623a200555a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031161623a200555a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2479755069","title":"华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479755069","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479755069?lang=zh_cn&edition=full","pubTime":"2024-10-31 02:43","pubTimestamp":1730313780,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布，附属东阿阿胶首九个月业绩，营业总收入43.29亿人民币，按年增加26.3%。录得净利润11.52亿人民币，增长46.7%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-30 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩普通股息：人民币 0.083 (相当于港元 0.0908)2024/03/26末期业绩普通股息：人民币 0.154 (相当于港元 0.1697)2023/10/31第三季业绩无派息2023/08/31中期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180322103035593_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180322103035593_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1392626/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["000423","BK0239","BK0183","03320","BK0010","BK0187","BK1191","BK1570","BK0196","SG9999014674.SGD","BK0188","BK0175","BK0028"],"gpt_icon":0},{"id":"2479452204","title":"华润医药(03320)：东阿阿胶前9个月实现净利润11.52亿元，同比增长46.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479452204","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479452204?lang=zh_cn&edition=full","pubTime":"2024-10-30 20:35","pubTimestamp":1730291729,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布东阿阿胶截至2024年9月30日止九个月业绩，营业总收入43.29亿元，同比增长26.28%;净利润11.52亿元，同比增长46.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000423","03320"],"gpt_icon":0},{"id":"2478116771","title":"华润医药：华润三九前三季度净利润32.45亿元 同比增加20.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478116771","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478116771?lang=zh_cn&edition=full","pubTime":"2024-10-28 08:53","pubTimestamp":1730076839,"startTime":"0","endTime":"0","summary":"华润医药（03320）发布华润三九医药股份有限公司（华润三九）（000999.SZ）截至2024年9月30日止9个月业绩，营业总收入人民币197.4亿元，同比增加6.08%；净利润人民币32.45亿元，同比增加20.39%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-28/doc-incuakcf9755270.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-28/doc-incuakcf9755270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["03320"],"gpt_icon":0},{"id":"2478151664","title":"华润医药(03320.HK)附属华润双鹤首九个月赚14.12亿人民币 增长2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478151664","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478151664?lang=zh_cn&edition=full","pubTime":"2024-10-27 19:03","pubTimestamp":1730026980,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布，持股60.21%附属华润双鹤首九个月业绩，营业总收入85.48亿人民币，按年增加1.2%。录得净利润14.12亿人民币，增长2%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-25 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩普通股息：人民币 0.083 (相当于港元 0.0908)2024/03/26末期业绩普通股息：人民币 0.154 (相当于港元 0.1697)2023/10/31第三季业绩无派息2023/08/31中期业绩无派息AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115742257_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115742257_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1391338/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03320","BK0185","BK0010","BK0239","BK1570","BK0175","BK1191","BK0028","600062","BK0188"],"gpt_icon":0},{"id":"2478136507","title":"2024国谈今日开启：默沙东、华润医药等多家药企现身首日，今年对创新药要求或更高","url":"https://stock-news.laohu8.com/highlight/detail?id=2478136507","media":"红星新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478136507?lang=zh_cn&edition=full","pubTime":"2024-10-27 14:14","pubTimestamp":1730009640,"startTime":"0","endTime":"0","summary":"创新药仍是各方关注重点。另有知情人士透露，此次国谈对临床数据、试验数据等的真实可靠性的要求越来越严格，这意味着对创新药有了更高要求。多家头部药企首日到场CAR-T、GLP-1等重磅品种备受关注国谈首日现场，默沙东、华润医药、百特药业、康缘药业、康哲药业、宜昌人福、正大天晴等多家药企被点名进入谈判现场。据悉，默沙东早上参谈药品是多拉米替片。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241027141506ab77d7f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241027141506ab77d7f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","IE00BBT3K403.USD","LU0861579265.USD","BK4550","LU0289739699.SGD","BK4516","IE00BJJMRZ35.SGD","LU0965508806.USD","LU0965509101.SGD","LU0985320562.USD","LU0058720904.USD","LU0320765489.SGD","IE0002141913.USD","LU0106261372.USD","LU1057294990.SGD","BK4559","LU0965509010.AUD","LU0234572021.USD","LU0265550946.USD","LU1061106388.HKD","LU1934455277.USD","LU0965509283.SGD","BK4007","LU1066051498.USD","MRK","IE00BLSP4452.SGD","LU0006306889.USD","LU0211331839.USD","LU1066051811.HKD","LU1585245621.USD","IE000M9KFDE8.USD","LU1093756168.USD","BK4588","LU0266013472.USD","IE00B4R5TH58.HKD","LU1941712264.USD","03320","LU0203345920.USD","LU0238689110.USD","LU0070302665.USD","LU1291159041.SGD","LU1934455194.USD","LU0208291251.USD","LU0265550359.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU1037948897.HKD","LU1934455863.HKD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2478873579","title":"华润医药(03320)：华润三九(000999.SZ)前三季度净利润32.45亿元 同比增加20.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478873579","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478873579?lang=zh_cn&edition=full","pubTime":"2024-10-25 20:59","pubTimestamp":1729861179,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布华润三九医药股份有限公司(华润三九)(000999.SZ)截至2024年9月30日止9个月业绩，营业总收入人民币197.4亿元，同比增加6.08%;净利润人民币32.45亿元，同比增加20.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","000999"],"gpt_icon":0},{"id":"2478989312","title":"华润医药(03320)：江中药业前三季度实现净利润6.84亿元，同比增长8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478989312","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478989312?lang=zh_cn&edition=full","pubTime":"2024-10-25 19:56","pubTimestamp":1729857383,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布公告，于2024年10月25日，江中药业公布其截至2024年9月30日止九个月的季度报告，营业总收入29.72亿元(人民币，下同)，同比减少8.19%;净利润6.84亿元，同比增长8.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600750","03320"],"gpt_icon":0},{"id":"2478988575","title":"华润医药(03320)：昆药集团前三季度实现净利润3.91亿元，同比减少1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478988575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478988575?lang=zh_cn&edition=full","pubTime":"2024-10-25 19:09","pubTimestamp":1729854560,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布昆药集团截至2024年9月30日止九个月业绩，营业总收入54.57亿元(人民币，下同),同比减少2.73%;净利润3.91亿元，同比减少1.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600422","03320"],"gpt_icon":0},{"id":"2478604111","title":"华润医药(03320)：华润双鹤前三季度净利润约14.12亿元，同比增长2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478604111","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478604111?lang=zh_cn&edition=full","pubTime":"2024-10-25 18:16","pubTimestamp":1729851398,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)公布华润双鹤2024年前9个月业绩，营业总收入约85.48亿元，同比增长1.18%;净利润约14.12亿元，同比增长2.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","600062"],"gpt_icon":0},{"id":"2478644339","title":"瑞银：首予华润医药“买入”评级 相信其未来几年将继续跑羸同行","url":"https://stock-news.laohu8.com/highlight/detail?id=2478644339","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478644339?lang=zh_cn&edition=full","pubTime":"2024-10-25 10:58","pubTimestamp":1729825134,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2477597216","title":"华润医药(03320.HK)附属华润博雅生物首九月赚4.12亿人民币 倒退13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477597216","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477597216?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:52","pubTimestamp":1729785120,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布，附属华润博雅生物9月止首九个月业绩，实现营业总收入12.45亿人民币，按年下降43.2%。录得净利润4.12亿人民币，倒退13%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-24 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩普通股息：人民币 0.083 (相当于港元 0.0908)2024/03/26末期业绩普通股息：人民币 0.154 (相当于港元 0.1697)2023/10/31第三季业绩无派息2023/08/31中期业绩无派息AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180321104350557_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180321104350557_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1390928/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0046","03320","BK1570","BK0197","BK0239","300294","BK1191"],"gpt_icon":0},{"id":"2477853816","title":"华润医药(03320)：华润博雅生物前三季度净利润约4.12亿元，同比减少13.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477853816","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477853816?lang=zh_cn&edition=full","pubTime":"2024-10-24 19:01","pubTimestamp":1729767714,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)公布华润博雅生物2024年前9个月业绩，营业总收入约12.45亿元，同比减少43.16%;净利润约4.12亿元，同比减少13.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","300294"],"gpt_icon":0},{"id":"2477503545","title":"瑞银：首予华润医药(03320)“买入”评级 目标价9.9港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477503545","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477503545?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:52","pubTimestamp":1729759934,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研究报告称，首次覆盖华润医药(03320)，予目标价9.9港元及评级“买入”。该行看好公司在非处方传统中医药市场的强劲存在及其强大的并购能力。该行预测，公司2023年至2028年的收入和盈利年均增长率分别为7.8%和7.9%，低于2020年至2023年的13.2%和11.6%增长率。基于这上述因素以及行业整合趋势，该行相信公司在未来几年将继续跑赢同行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320"],"gpt_icon":0},{"id":"2477579988","title":"《大行》瑞银首次覆盖华润医药(03320.HK) 评级“买入”目标价9.9元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477579988","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477579988?lang=zh_cn&edition=full","pubTime":"2024-10-24 15:10","pubTimestamp":1729753800,"startTime":"0","endTime":"0","summary":"瑞银首次覆盖华润医药(03320.HK) ，予目标价9.9元及评级“买入”。该行指，看好公司在非处方传统中医药市场的强劲存在及其强大的并购能力。该行预测公司2023年至2028年的收入和盈利年均增长率分别为7.8%和7.9%，低于2020年至2023年的13.2%和11.6%增长率。基于这上述因素以及行业整合趋势，该行相信公司在未来几年将继续跑羸同行。(vc/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-24 12:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1390819/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03320"],"gpt_icon":0},{"id":"2477348357","title":"南向资金10月22日净卖出华润医药207.15万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2477348357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477348357?lang=zh_cn&edition=full","pubTime":"2024-10-23 09:30","pubTimestamp":1729647018,"startTime":"0","endTime":"0","summary":"10月22日，南向资金减持华润医药207.15万股连续3日减持。截止当日收盘，港股通共持有华润医药32096.81万股，占流通股5.10%。华润医药近5个交易日上涨4.06%，港股通累计减持603.15万股；近20个交易日上涨18.47%，港股通累计减持350.50万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410230932239f57a630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410230932239f57a630&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2477801774","title":"华润医药10月22日主力资金流入713万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2477801774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477801774?lang=zh_cn&edition=full","pubTime":"2024-10-22 16:16","pubTimestamp":1729584991,"startTime":"0","endTime":"0","summary":"10月22日, 华润医药股价涨0.51%，报收5.90元，成交金额4209万元，换手率0.11%，振幅2.04%，量比0.60。华润医药今日主力资金净流入713万元，连续3日净流入，上一交易日主力净流入322万元，今日环比增加121.43%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为30.00%，平均涨幅为4.87%。该股近5个交易日上涨3.88%，主力资金累计净流入735万元；近20日主力资金累计净流出344万元，其中净流出天数为10日。该股主力净额占比0.02%，港股市场排名184/2640。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221617059f55fa7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221617059f55fa7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2477024840","title":"【港股通】华润医药(03320)附属拟至多1.2亿人币增持江中药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2477024840","media":"金吾财讯","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477024840?lang=zh_cn&edition=full","pubTime":"2024-10-22 08:59","pubTimestamp":1729558756,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药(03320)公告，公司非全资附属华润江中制药集团拟于12个月内通过上海证券交易所增持江中药业(600750)股份，增持总金额不低于6000万元人民币及不超过1.2亿元人民币。华润江中目前持有江中药业约43.09%股权，为江中药业控股股东，而该集团实际控制江中药业约26.09%，并以附属公司形式入帐。至于增持计划不设定价格区间，将根据对江中药业股票价值判断及二级市场波动情况实施增持计划。华润江中拟通过自有资金或自筹资金增持江中药业A股，且承诺在增持计划实施期限内及法定期限内不减持所持江中药业股份。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200915/MTQ3MGYxNDE0OGI1OTUxMGM4OTJjZmIwYjlmNjI1MDU4NDg4OA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/MTQ3MGYxNDE0OGI1OTUxMGM4OTJjZmIwYjlmNjI1MDU4NDg4OA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946220","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600750","BK0188","HSCEI","BK0175","BK1191","HSTECH","BK0239","YANG","BK1570","BK0028","03320"],"gpt_icon":0},{"id":"2477861199","title":"华润医药(03320.HK)附属江中药业控股股东拟最多1.2亿人民币增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2477861199","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477861199?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:37","pubTimestamp":1729521420,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布，沪A附属江中药业控股股东华润江中拟即日起十二个月内，增持江中药业股份，总金额不低于6,000万人民币，不超过1.2亿人民币。目前，江中药业由公司非全资附属华润江中持股43.09%，集团实际制江中药业约26.09%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-21 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1389814/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0175","BK0188","BK0028","600750","03320","BK1570","BK1191","BK0239"],"gpt_icon":0},{"id":"2477383702","title":"华润医药(03320)：华润江中拟增持江中药业股份 增持总金额为0.6亿元-1.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477383702","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477383702?lang=zh_cn&edition=full","pubTime":"2024-10-21 18:21","pubTimestamp":1729506101,"startTime":"0","endTime":"0","summary":"(三)拟增持股份的数量及金额：总体增持金额不低于0.6亿元人民币(含)，不超过1.2亿元人民币(含)。增持计划实施期间内，江中药业股票因筹划重大事项连续停牌10个交易日以上的，增持计划在股票复牌后顺延实施。(七)增持主体承诺：华润江中承诺在增持计划实施期限内及法定期限内不减持其所持有的江中药业股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1570","03320","BK0188","600750","BK0239","BK0028","BK0175","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":-0.0243},{"period":"1month","weight":-0.1498},{"period":"3month","weight":0.0495},{"period":"6month","weight":0.0812},{"period":"1year","weight":0.1602},{"period":"ytd","weight":0.1149}],"compareEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0954},{"period":"3month","weight":0.2355},{"period":"6month","weight":0.1231},{"period":"1year","weight":0.1644},{"period":"ytd","weight":0.2065}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案，如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008478},{"month":2,"riseRate":0.75,"avgChangeRate":0.055041},{"month":3,"riseRate":0.5,"avgChangeRate":-0.02417},{"month":4,"riseRate":0.875,"avgChangeRate":0.053308},{"month":5,"riseRate":0.5,"avgChangeRate":0.006748},{"month":6,"riseRate":0.375,"avgChangeRate":0.006122},{"month":7,"riseRate":0.125,"avgChangeRate":-0.056809},{"month":8,"riseRate":0.5,"avgChangeRate":0.011562},{"month":9,"riseRate":0.25,"avgChangeRate":-0.023565},{"month":10,"riseRate":0.125,"avgChangeRate":-0.03496},{"month":11,"riseRate":0.555556,"avgChangeRate":0.023106},{"month":12,"riseRate":0.5,"avgChangeRate":-0.002995}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}